30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q13 Revenue: Bacterin

$8.6MM, +11%

Growth attributed to new sales agreement with large U.S. distributor, contributing $1.3MM

  • Signed agreement with AATB-accredited tissue bank for tissue recovery
  • Enrolled 1st patient in OsteoSponge SC registry; expects to enroll 75 patients within “next year or so”
  • Planning to counter price sensitivity by working with channel partners (e.g., preferred vendor for a regional 40-hospital chain), bundling products, emphasizing education about biologics
  • Current processing capabilities support 40 donors/month
  • 51 direct sales reps to date